Assay for vitamin B12 absorption and method of making labeled vitamin B12
View Patent ↗The invention provides methods for labeling vitamin B12 with 14 C, 13 C, tritium, and deuterium. When radioisotopes are used, the invention provides for methods of labeling B12 with high specific activity. The invention also provides labeled vitamin B12 compositions made in accordance with the invention.
1. A method of determining absorption of vitamin B12 in a subject, said method comprising:
(a) orally administering B12 labeled with 14 C, 13 C, deuterium, or tritium to said subject, wherein the specific activity of the labeled B12 is at least 10 Ci/mol and the B12 mass is less than 10 μg;
(b) taking a blood sample from said subject,
(c) subjecting said blood sample to mass spectroscopy and measuring elevation of 14 C, 13 C, or tritium associated with the labeled B12 above background 14 C, 13 C, deuterium, or tritium concentrations, respectively and
(d) comparing said concentration of labeled B12 found in the subject to the concentration of B12 in subjects with normal B12 absorption to determine the B12 absorption in the subject.
2. A method of claim 1 , wherein said mass spectroscopy is accelerator mass spectroscopy.
3. A method of claim 2 , wherein said label is 14 C or tritium.
4. A method of studying vitamin B12 metabolism in a subject, said method comprising:
(a) orally administering B12 labeled with 14 C, 13 C, deuterium, or tritium to said subject, wherein the specific activity of the labeled B12 is at least 10 Ci/mol and the B12 mass is less than 10 μg;
(b) taking a blood sample from said subject,
(c) subjecting said blood sample to mass spectroscopy and measuring elevation of 14 C, 13 C, or tritium associated with the labeled B12 above background 14 C, 13 C, deuterium, or tritium concentrations, respectively and
(d) comparing said concentration of labeled B12 found in the subject to the concentration of B12 in subjects with normal B12 absorption.
5. A method of claim 4 , wherein said vitamin B12 metabolism is plasma clearance, turnover rate, enzyme kinetic measurement, or uptake and distribution of the vitamin.
6. The method of claim 1 , wherein the 14 C, 13 C, deuterium, or tritium is present on a dimethylbenzimidazole moiety of the labeled B12.
7. The method of claim 1 , wherein the specific activity of the labeled B12 is at least 25 Ci/mol.
8. The method of claim 4 , wherein the specific activity of the labeled B12 is at least 25 Ci/mol.